Literature DB >> 24911439

Lack of effect of risperidone or olanzapine dose reduction on metabolic parameters, prolactin, and corrected QT interval in stable patients with schizophrenia.

Hiroyoshi Takeuchi1, Takefumi Suzuki, Gary Remington, Koichiro Watanabe, Masaru Mimura, Hiroyuki Uchida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24911439     DOI： 10.1097/JCP.0000000000000142

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  2 in total

1.  Olanzapine-Induced Hyperprolactinemia: Two Case Reports.

Authors:  Pedro Cabral Barata; Mário João Santos; João Carlos Melo; Teresa Maia
Journal:  Front Pharmacol       Date:  2019-07-29       Impact factor: 5.810

2.  Reversibility of Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis.

Authors:  Helene Speyer; Casper Westergaard; Nikolai Albert; Mette Karlsen; Anne Emilie Stürup; Merete Nordentoft; Jesper Krogh
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-28       Impact factor: 5.555
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.